Theriva Biologics, Inc. — Institutional Ownership
Which tracked institutions hold TOVX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
6
Funds holding
$42914
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $20692 | 82700 | +82700 | NEW BUY |
| 2 | Ubs Group Ag | $15264 | 61053 | +61053 | NEW BUY |
| 3 | Morgan Stanley | $5079 | 20299 | -3303 | -13.99% |
| 4 | Blackrock, Inc. | $1878 | 7504 | — | Held |
| 5 | Barclays Plc | $1 | 3 | +3 | NEW BUY |
| 6 | Royal Bank Of Canada | $0 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.